cas 131052-58-9|| where to buy 1,2-oxazol-3-ylmethanamine

Nombre del producto:1,2-oxazol-3-ylmethanamine

IUPAC Name:1-(1,2-oxazol-3-yl)methanamine

Unidad de embalaje	Stock disponible	Precio($)
CM105127-100mg	in stock	Ǒȯȯ
CM105127-250mg	in stock	ǑȐǶ
CM105127-1g	in stock	ƛƿƿ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 131052-58-9 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :131052-58-9; Fórmula molecular:C4H6N2O; Punto de fusión:-; Código de sonrisas:NCC1=NOC=C1; Densidad:

: Número de catálogo:CM105127; Peso molecular:98.11; Punto de ebullición:; Nº Mdl:MFCD06738791; Almacenamiento:

: Isoxazoles; Isoxazole is a liquid heterocyclic compound C3H3NO isomeric with oxazole and having a penetrating odor like that of pyridine. Isoxazoles belong to an important class of five-membered aromatic heterocycles containing two electronegative heteroatoms, nitrogen and oxygen, in a 1,2-relationship and three regular sp2 carbon atoms. These molecules are found to be key components in various synthetic products in daily use and also present as a pharmacophore essential for biological activity in many drugs and bioactive natural products. In addition, isoxazoles have demonstrated their ability to exhibit hydrogen bond donor/acceptor interactions with a variety of enzymes and receptors.

: Oxazoles; Oxazoles are heterocyclic aromatic compounds containing one oxygen atom and one nitrogen atom, separated by a carbon atom. The presence of two heteroatoms (oxygen and nitrogen) provides possible interactions (hydrogen, hydrophobic, van der Waals or dipole bonds) with a wide range of receptors and enzymes. Oxazole rings are valuable heterocyclic scaffolds for the design of novel therapeutics with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic, and antidepressant properties due to their wide range of targets and biological activities.